Inventor
DASSEUX JEAN-LOUIS
DE47 patents
⚠️ This page may combine multiple inventors who share the name “DASSEUX JEAN-LOUIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
(unassigned)
11 patentsUS6753313B1Jun 22, 2004
Multimeric Apoa-I agonist compounds
73 citations99
US6602854B1Aug 5, 2003
Branched multimeric Apo A-I agonist compounds
79 citations99
US6287590B1Sep 11, 2001
Peptide/lipid complex formation by co-lyophilization
107 citations99
US6265377B1Jul 24, 2001
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
83 citations98
US6716816B1Apr 6, 2004
Multimeric Apo A-I agonist compounds
52 citations96
US6630450B1Oct 7, 2003
Method of treating dyslipidemia
58 citations96
US6573239B1Jun 3, 2003
Apolipoprotein A-I agonist compounds
62 citations96
US6518412B1Feb 11, 2003
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
64 citations96
US6455088B1Sep 24, 2002
Peptide/lipid complex formation by co-lyophilization
66 citations96
US6900177B1May 31, 2005
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
27 citations92
US6844327B2Jan 18, 2005
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
28 citations92
DASSEUX JEAN-LOUIS
9 patentsUS6376464B1Apr 23, 2002
Lipid complexes of APO A-1 agonist compounds
DASSEUX JEAN-LOUIS116 citations99
US8617615B2Dec 31, 2013
Charged lipoprotein complexes and their uses
DASSEUX JEAN-LOUIS12 citations93
US8206750B2Jun 26, 2012
Charged lipoprotein complexes and their uses
DASSEUX JEAN-LOUIS23 citations93
US7312190B2Dec 25, 2007
Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
DASSEUX JEAN-LOUIS13 citations92
US7307058B2Dec 11, 2007
Multimeric Apo A-I agonist compounds
DASSEUX JEAN-LOUIS11 citations92
US7273848B2Sep 25, 2007
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
DASSEUX JEAN-LOUIS12 citations92
US7189689B2Mar 13, 2007
Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders
DASSEUX JEAN-LOUIS17 citations92
US7157425B2Jan 2, 2007
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
DASSEUX JEAN-LOUIS12 citations92
US7211565B2May 1, 2007
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
DASSEUX JEAN-LOUIS19 citations88
CERENIS THERAPEUTICS HOLDING S A
6 patentsUS9187551B2Nov 17, 2015
Lipoprotein complexes and manufacturing and uses thereof
CERENIS THERAPEUTICS HOLDING S A16 citations91
US11376309B2Jul 5, 2022
Lipoprotein complexes and manufacturing and uses thereof
CERENIS THERAPEUTICS HOLDING S A7 citations84
US9567388B2Feb 14, 2017
Charged lipoprotein complexes and their uses
CERENIS THERAPEUTICS HOLDING S A6 citations84
US10328119B2Jun 25, 2019
Lipoprotein complexes and manufacturing and uses thereof
CERENIS THERAPEUTICS HOLDING S A8 citations83
US10322163B2Jun 18, 2019
Lipoprotein complexes and manufacturing and uses thereof
CERENIS THERAPEUTICS HOLDING S A8 citations83
US11801282B2Oct 31, 2023
Charged lipoprotein complexes and their uses
CERENIS THERAPEUTICS HOLDING S A0 citations62
ABIONYX PHARMA SA
6 patentsUS11998587B2Jun 4, 2024
Lipoprotein complexes and manufacturing and uses thereof
ABIONYX PHARMA SA1 citations71
US11969456B2Apr 30, 2024
Lipoprotein complexes and manufacturing and uses thereof
ABIONYX PHARMA SA1 citations71
US11752163B2Sep 12, 2023
CER-001 therapy for treating kidney disease
ABIONYX PHARMA SA2 citations64
US12220462B1Feb 11, 2025
Complexes for delivery of cyclic dinucleotides
ABIONYX PHARMA SA0 citations62
US12364735B2Jul 22, 2025
Lipoprotein complexes and manufacturing and uses thereof
ABIONYX PHARMA SA0 citations61
US12364705B2Jul 22, 2025
CER-001 therapy for treating kidney disease
ABIONYX PHARMA SA0 citations53
CERENIS THERAPEUTICS HOLDING SA
4 patentsUS9388232B2Jul 12, 2016
Apolipoprotein A-I mimics
CERENIS THERAPEUTICS HOLDING SA8 citations82
US8378068B2Feb 19, 2013
Apolipoprotein A-I mimics
CERENIS THERAPEUTICS HOLDING SA8 citations82
US8993597B2Mar 31, 2015
Apolipoprotein A-I mimics
CERENIS THERAPEUTICS HOLDING SA1 citations60
US9981008B2May 29, 2018
Apolipoprotein A-I mimics
CERENIS THERAPEUTICS HOLDING SA0 citations50
DASSEUX JEAN LOUIS
3 patentsUS6046166AApr 4, 2000
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
DASSEUX JEAN LOUIS192 citations99
US6037323AMar 14, 2000
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
DASSEUX JEAN LOUIS298 citations99
US6734169B2May 11, 2004
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
DASSEUX JEAN LOUIS68 citations96
ESPERION THERAPEUTICS INC
3 patentsUS6329341B1Dec 11, 2001
Method of treating septic shock
ESPERION THERAPEUTICS INC61 citations96
US7304093B2Dec 4, 2007
Ketone compounds and compositions for cholesterol management and related uses
ESPERION THERAPEUTICS INC34 citations92
US6953840B2Oct 11, 2005
Methods of using non-human animal Apolipoprotein A-I protein
ESPERION THERAPEUTICS INC21 citations90
PFIZER
3 patentsUS7250407B2Jul 31, 2007
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
PFIZER16 citations92
US7566695B2Jul 28, 2009
Multimeric apoprotein agonists
PFIZER9 citations84
US7994120B2Aug 9, 2011
Method of treating dyslipidemic disorder
PFIZER11 citations79